Clinical Trial Results:
Immunogenicity, Reactogenicity and Safety of the Trivalent
Influenza Subunit Vaccine Influvac® for the Northern
Hemisphere Season 2012/2013. An Open-Label, Baseline-
Controlled Study in Two Age Groups: Adult Subjects ≥ 18 and
≤ 60 Years and Elderly Subjects ≥ 61 Years of Age.
Summary
|
|
EudraCT number |
2012-001032-57 |
Trial protocol |
DE BE |
Global completion date |
25 Jul 2012
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
07 Aug 2019
|
First version publication date |
07 Aug 2019
|
Other versions |
|
Summary report(s) |
M13-567-Synopsis_Redacted |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.